Histone H2AX Is Phosphorylated at Sites of Retroviral DNA Integration but Is Dispensable for Postintegration Repair by Daniel, René et al.
Histone H2AX Is Phosphorylated at Sites of Retroviral DNA
Integration but Is Dispensable for Postintegration Repair*
Received for publication, July 13, 2004, and in revised form, August 10, 2004
Published, JBC Papers in Press, August 11, 2004, DOI 10.1074/jbc.M407886200
Rene´ Daniel‡§¶, Joseph Ramcharan‡§, Emmy Rogakou**, Konstantin D. Taganov‡ ‡‡,
James G. Greger‡, William Bonner, Andre´ Nussenzweig§§, Richard A. Katz‡,
and Anna Marie Skalka‡¶¶
From the ‡Fox Chase Cancer Center, Institute for Cancer Research, Philadelphia, Pennsylvania 19111-2497,
Laboratory of Molecular Pharmacology, NCI, National Institutes of Health, Bethesda, Maryland 20892,
and §§Experimental Immunology Branch, NCI, National Institutes of Health, Bethesda, Maryland 20892
The histone variant H2AX is rapidly phosphorylated
(denoted H2AX) in large chromatin domains (foci)
flanking double strand DNA (dsDNA) breaks that are
produced by ionizing radiation or genotoxic agents and
during V(D)J recombination. H2AX-deficient cells and
mice demonstrate increased sensitivity to dsDNA break
damage, indicating an active role for H2AX in DNA
repair; however, H2AX formation is not required for
V(D)J recombination. The latter finding has suggested a
greater dependence on H2AX for anchoring free bro-
ken ends versus ends that are held together during pro-
grammed breakage-joining reactions. Retroviral DNA
integration produces a unique intermediate in which a
dsDNA break in host DNA is held together by the inter-
vening viral DNA, and such a reaction provides a useful
model to distinguish H2AX functions. We found that
integration promotes transient formation of H2AX at
retroviral integration sites as detected by both immuno-
cytological and chromatin immunoprecipitation meth-
ods. These results provide the first direct evidence for
the association of newly integrated viral DNA with a
protein species that is an established marker for the
onset of a DNA damage response. We also show that
H2AX is not required for repair of the retroviral integra-
tion intermediate as determined by stable transduction.
These observations provide independent support for an
anchoringmodel for the function of H2AX in chromatin
repair.
The evolutionarily conserved histone H2AX comprises ap-
proximately 2–25% of the histone H2A pool in mammalian cells
and is incorporated randomly into nucleosomes (1). The ex-
tended C-terminal tail of H2AX contains a serine (Ser-139)
embedded in an invariant SQE motif that is a target for phos-
phorylation by the phosphatidylinositol 3-kinase-related DNA-
PK, ataxia-telangiectasia-mutated (ATM), and ATM and Rad3-
related (ATR) protein kinases (2–4). This H2AX serine residue
is massively and rapidly phosphorylated at sites of double
strand breaks (DSBs)1 and stalled replication forks (3, 5, 6),
forming microscopically visible foci on staining with a specific
antibody. This phosphorylation seems to play an important role
in processing or repair of DSBs (7, 8). H2AX phosphorylation
has also been observed at sites of V(D)J recombination (9),
meiotic strand breaks, and other physiologically programmed
reactions in which DSBs are formed (10–12).
Early events in retroviral replication include entry of the
viral capsid with the accompanying enzymes reverse tran-
scriptase and integrase (IN) followed by synthesis of a DNA
copy of the viral RNA genome to form a preintegration complex.
This complex then enters the nucleus, and integration is first
detected at approximately 3–4 h postinfection (13). Retroviral
integration is catalyzed by integrase acting on specific se-
quences at the ends of the viral DNA and via a concerted
cleavage-ligation reaction that is mechanistically similar to
that catalyzed by RAG proteins during V(D)J recombination
(14–16) (Fig. 1A). As a consequence of integrase-mediated join-
ing, the host cell DNA suffers a DSB, but the ends are held
together by single strand links to viral DNA (Fig. 1B). Postin-
tegration repair of this intermediate (Fig. 1B) is essential for
the maintenance of host DNA integrity as well as the stable
association of retroviral DNA with host chromosomes. Numer-
ous lines of evidence (17–20) indicate that retroviral DNA
elicits a DNA damage response and that the integration inter-
mediate is repaired primarily via components of the non-ho-
mologous end-joining (NHEJ) pathway. In this study, we asked
whether H2AX is phosphorylated at sites of retroviral DNA
integration and whether this response is essential for repair of
this complex lesion as determined by survival of stably trans-
duced cells.
EXPERIMENTAL PROCEDURES
Cells and Viruses—MO59K cells (purchased from American Type
Culture Collection) were maintained as described previously (18, 19),
and mouse embryonic fibroblasts (MEFs) were maintained as described
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previously (17). The ASV-based vectors IN and IN and the HIV-1-
based vector were described previously (17, 19).
Immunofluorescence and Quantification of Foci—Cells were plated
and infected the following day at multiplicity of infection (m.o.i.) 10. The
cells were washed with phosphate-buffered saline and fixed with 4%
paraformaldehyde at the indicated times postinfection. After permeabi-
lization with 0.2% Triton X-100, samples were blocked overnight with
3% bovine serum albumin at 4 °C. The slides were incubated with a
mouse monoclonal antibody against H2AX (Upstate) and then with
Alexa Fluor 488 conjugated goat anti-mouse IgG (Molecular Probes) as
secondary antibody. Nuclei were stained with 4,6-diamidino-2-phe-
nylindole prior to mounting the slides with SlowFade antifade reagent
(Molecular Probes).
Processed cells were examined for H2AX foci by monitoring fluores-
cence of the Alexa Fluor dye using an UltraView confocal imaging
system (PerkinElmer Life Sciences) in which the confocal scanning
head was mounted on a Nikon TE-200E microscope. Optical sections
along the z axis of the nuclei were captured at 0.1-m intervals, and the
final images were obtained by projection of the individual sections. For
each time point, images of at least 100 cells were captured and used for
quantitative analysis of H2AX foci. To prevent bias in the selection of
cells that displayed foci, nuclei were randomly selected for 4,6-dia-
midino-2-phenylindole staining and then monitored for focus formation.
The H2AX foci were counted in each cell using Image-Pro Plus (Media
Cybernetics). A setting that excluded relatively weak foci and back-
ground speckles was used as a standard for foci quantitation in all the
cells selected for analysis.
A simple stochastic model for viral integration and formation of
H2AX foci was designed to relate the number of foci counted in cells to
the time of observation. Virus is modeled as being integrated at 4 h, on
average, after the start of the experiment. The exact time of integration
and start of H2AX phosphorylation are taken to be normally distrib-
uted, with a mean of 4 h and a standard deviation of 1.1 h. H2AX
phosphorylation is modeled to continue for an exponentially distributed
random time, with a mean of 2.6 h. The number of viruses integrating
in a cell is taken to be Poisson distributed. The best fit to experimental
data is achieved with a mean m.o.i. of 8.5 viruses/cell.
Chromatin Immunoprecipitation—Chromatin immunoprecipitation
(ChIP) assays were performed as described by Boyd and Farnham (21).
In our experiments, 106 HeLa cells were infected with amphotropic ASV
vectors IN or IN (17). At defined times after infection, formaldehyde
(1% final) was added, and the cultures were incubated at room temper-
ature for 30 min to cross-link viral DNA and interacting proteins. The
cross-linking reaction was quenched with glycine (0.125 M final concen-
tration). Plates were washed with cold 1 phosphate-buffered saline,
and then cells were scraped into 1 phosphate-buffered saline that
contained protease inhibitors and washed and lysed by addition of 0.5%
Nonidet P-40, 5 mM PIPES, pH 8.0, 85 mM KCl, and protease inhibitors.
The intact nuclei were isolated by centrifugation at 5000 rpm at 4 °C.
Nuclei were then resuspended in a lysis buffer (1% SDS, 50 mM Tris-Cl,
pH 8.1, 10 mM EDTA, protease inhibitors). Chromatin was sonicated to
fragments containing DNA of an average length of approximately 600
bp. Samples were subjected to centrifugation to remove debris and were
precleared by shaking for 1 h with salmon sperm DNA/protein A-
agarose (Upstate). After removal of the salmon sperm DNA/protein
A-agarose, supernatants were diluted 10-fold with a dilution buffer
(0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-Cl, pH 8.1,
167 mM NaCl, protease inhibitors), and chromatin fragments were
immunoprecipitated overnight with antibodies to ASV integrase (rabbit
polyclonal), H2AX (mouse monoclonal) (Upstate), and phosphatidyl-
inositol 3-kinase p110 (mouse monoclonal) (Santa Cruz Biotechnology)
proteins. Protein-DNA-antibody complexes were isolated by the addi-
tion of salmon sperm DNA/protein A-agarose. After 1 h, complexes were
collected by centrifugation and washed three times with a wash buffer
(100 mM Tris, pH 8, 500 mM LiCl, 1% Nonidet P-40, 1% deoxycholic
acid). Pellets were eluted with 50 mM NaHCO3, 1% SDS for 15 min at
room temperature. Clarified samples were incubated with RNase and 5
M NaCl at 67 °C for 4–5 h to reverse cross-links and then precipitated
overnight with ethanol. Following centrifugation, pellets were resus-
pended in proteinase K buffer and treated with proteinase K. After
phenol/chloroform extraction, the DNA was precipitated with ethanol.
Viral sequences in these fractions were detected by PCR using primers
targeting the long terminal repeats. The sequence of the left primer was
5-ACG TCC AGG GCC CGG AGC GAC-3, and the right primer was
5-CTT CAA TGC CCC CAA AAC CAA-3. PCR products were resolved
by electrophoresis on an agarose gel and subjected to Southern blotting
with a radioactive probe against the ASV long terminal repeat (gener-
ated by using random primers and a PCR fragment made with the long
terminal repeat probe primers 5-GAT TGG TGG AAG TAA GGT GG-3
and 5-CAA ATG GCG TTT ATT GTA TCG-3). As a negative control,
we used primers targeting the cellular p21 promoter sequences, left,
5-TTT CCA CCT TTC ACC ATT CC-3, and right, 5-GGC AGA TCA
CAT ACC CTG TT-3, with a probe generated by using random primers.
Transduction Assays—For infection with the ASV vector (22), MEFs
were plated at a density of 105 cells/60-mm dish. On the following day,
cells were infected in the presence of 5 g/ml DEAE-dextran. At 8 days
postinfection, EGFP-positive cells were counted by flow cytometry. For
infection with the HIV-1 vector, MEFs were plated at a density of 5 
104 cells/well in a 24-well plate. The following day, cells were infected
with an HIV-1 EGFP vector (23). Transduced cells were counted by flow
cytometry as with the ASV vector.
RESULTS
To determine whether retroviral infection induces formation
of H2AX foci, we infected cells with an amphotropic ASV
vector (17) and examined them by immunofluorescence with an
antibody specific for H2AX. In preliminary experiments (data
not included), we observed the formation of H2AX foci early
after infection in DNA repair-proficient human (HeLa and
FIG. 1. Stable, heritable establish-
ment of a retroviral provirus re-
quires integrase-mediated DNA inte-
gration and postintegration repair of
the integration intermediate by host
proteins. A, the first two steps in this
process are catalyzed by a multimer of
integrase, (IN)n. B, postintegration repair
is dependent on host cell functions.
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MO59K) and mouse (3T3) cells. As a control, we infected cells
with an integration-deficient (IN) vector (17), and no increase
in foci over background was detected. The data in Fig. 2 and
Table I summarize results from subsequent experiments,
which included computer-assisted quantitative analyses of
H2AX foci in MO59K cells infected at m.o.i. 10 infectious
particles/cell. We again observed an increased number of foci in
the infected culture (Fig. 2A), which appeared to peak at 6 h
postinfection. A comparison of the distribution of the number of
foci/cell in uninfected cells with the number of foci/cell 6 h
postinfection is shown in Fig. 2B. The bulk (75%) of the
uninfected cells contained no or few foci/cell, whereas a small
proportion (10%) displayed numerous foci, which we specu-
late may have been caused by replication stress; such cells were
also observed in the infected culture. At 6 h postinfection, the
infected culture had many fewer cells with no foci, and the
percentage of cells with 5–10 foci was substantially higher than
in the uninfected culture. As summarized in Table I, this value
increased sharply by 4 h postinfection, when integration is
expected to begin. The average number of virus-induced foci
peaked at 5.1 foci/cell in the 6-h sample and declined again at
8 h postinfection. H2AX foci are reported (6) to arise within
minutes at sites of DNA damage and start to disappear after 30
min, with an 2-h half-life as damage is repaired. Assuming
similar kinetics, it is likely that some integration-induced foci
were both formed and resolved within the 8-h interval moni-
tored in this experiment. A computer simulation using such
parameters produced data consistent with the numbers of vi-
rus-induced foci/cell in a culture infected at m.o.i. 10, at the
postinfection time points shown in Table I.
To verify that H2AX is phosphorylated at sites of retroviral
DNA integration, we immunoprecipitated chromatin from nu-
clear extracts with a H2AX-specific antibody (ChIP assay) and
screened for the presence of viral DNA using PCR. To test the
feasibility of this approach, ChIP was first performed at 6 h
postinfection of HeLa cells at m.o.i. 0.001, 0.01, or 0.1 infectious
particles/cell (Fig. 3A, lanes 2–4). As expected, antibody specific
for integrase protein (positive control) precipitated viral DNA
in this extract and in amounts proportional to the m.o.i. An
association of viral DNA with the H2AX immunoprecipitate
was also readily detected and, as with integrase, in proportion
to the m.o.i. Approximately 10% of the viral DNA was co-
immunoprecipitated with H2AX in this test. Based on the
calculated efficiency of the antibody used for these analyses
(data not shown), the actual amount of nuclear viral DNA
associated with H2AX in this experiment is estimated to be
37% of the total. No association of viral DNA was detected
with the phosphatidylinositol 3-kinase antibody (negative con-
trol). In addition, none of the antibodies precipitated sequences
corresponding to a region in the cellular p21 promoter (DNA
negative control). In this experiment, viral DNA was quantified
by Southern blot, but comparable results were obtained with
real time PCR (not shown). Because results with m.o.i. 0.1 are
clearly in the titratable range for ChIP analysis, this was the
condition adopted in the two separate experiments summa-
rized in Fig. 3, B and C. Fig. 3B shows results of ChIP analyses
following infection with integration-competent (IN) or inte-
gration-defective (IN) ASV vectors. A peak of association of
H2AX and viral DNA was observed in the IN infection at 6 h
postinfection, and no association was detected after infection
with the IN vector. This result demonstrates that H2AX is
associated with nuclear viral DNA only after this DNA is
integrated into chromatin.
To examine more closely the kinetics of accumulation of
H2AX at integration sites, the amount of viral DNA captured
by ChIP at 2-h intervals was determined up to 16 h postinfec-
tion (Fig. 3C). Values for each time point were expressed as a
percentage of the total viral DNA in the nuclear fraction that is
associated with the ChIP at each time, corrected for immuno-
precipitation efficiency of the H2AX antibody. Consistent with
our analysis of foci in infected MO59K cells (Table I), these
results showed that an association with H2AX peaks at 6 h,
shortly after viral DNA is detected in the nuclear extract. We
estimate that 60% of the nuclear viral DNA in this experiment
is associated with H2AX and therefore is integrated at this
time point. From these results, we conclude that H2AX is a
valid marker for sites of retroviral DNA integration. We note
that ChIP detects integrated viral DNA both before and after
repair (Fig. 1). To examine the functional relevance of H2AX
phosphorylation to repair, we performed the transduction as-
says described below.
Because transduced genes are expressed efficiently only from
stably integrated proviruses, retroviral transduction is a read-
out for successful postintegration repair. For example, we have
shown that the transduction efficiency of NHEJ-defective
DNA-PKcs-deficient murine cells is reduced by 80–90% com-
FIG. 2. Retroviral infection induces formation of H2AX foci.
A, confocal images show uninfected MO59K cells (left) and 6 h postin-
fection with an ASV vector at m.o.i. 10 (right). Nuclei were stained with
4,6-diamidino-2-phenylindole (blue). B, distribution of foci is shown in
uninfected cells (open bars) and in cells 6 h after infection (filled bars).
TABLE I
Quantitative assessment of H2AX foci formation in response to
retroviral infection in MO59K cells
Cells were infected at an m.o.i. of 10, fixed with paraformaldehyde at
the indicated times following infection, and immunostained with
H2AX antibody. The number of foci/cell as well as the percentage of
cells displaying foci for an 8-h time course postinfection were deter-
mined as described under “Experimental Procedures.” The number of
virus-induced foci/cell was determined by subtracting the background
foci in uninfected cells (time 0) from the various time points.
Time
postinfection
Percentage of cells
with foci
No. of
foci/cell
No. of virus
induced foci/cell
h
0 53 5.2 0.0 (0.00)a
2 51 5.5 0.3 (0.26)
4 92 8.6 3.4 (3.41)
6 88 10.3b 5.1 (4.88)
8 84 8.2 3.0 (3.05)
a The numbers in parentheses are from the computer simulation
described under “Experimental Procedures.”
b p  106 for this time point.
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pared with wild type cells or deficient cells into which DNA-
PKcs-expressing DNA was reintroduced (17, 20). As the DNA
damage induced by integration cannot be repaired efficiently,
most NHEJ-deficient cells are unlikely to survive infection and
therefore cannot give rise to stable transductants. To find out
whether H2AX phosphorylation is required for postintegration
repair, we performed transduction experiments using MEF
lines obtained from H2AX knock-out mice and derivatives (24,
25), and the ASV-EGFP vector. Results in Table II show that
there is no significant difference between the transduction
efficiency with H2AX/ and H2AX/MEFs. Similar results
were obtained with a VSV-G protein-pseudo-typed HIV-1 GFP
vector (not shown). These data indicate that H2AX deficiency
has little or no effect on postintegration repair. One possible
explanation for this result is that H2AX function in these cells
is redundant. We therefore examined transduction in
H2AX/MEFs that had been complemented with transgenes
that express wild type murine H2AX or proteins carrying ei-
ther neutral non-modifiable substitutions (S136A/S139A) or
negatively charged substitutions that mimic constitutive phos-
phorylation (S136E/S139E) in the C-terminal phosphatidyli-
nositol 3-kinase-related protein kinase target sites of H2AX. No
significant difference was observed between the efficiencies of
transduction of these lines compared with H2AX/ cells (Ta-
ble I). It appears, therefore, that H2AX phosphorylation is
dispensable for postintegration repair.
DISCUSSION
In this study, we show that retroviral infection induces the
formation of histone H2AX foci, and chromatin immunopre-
cipitation assays confirmed that H2AX phosphorylation occurs
at sites of retroviral DNA integration. Therefore, these results
are consistent with our previous findings (17–20) that cells
respond to retroviral DNA integration in a manner similar to
DSBs. We also demonstrate that an H2AX deficiency and an
inability to phosphorylate this histone have no detectable effect
on the efficiency of retroviral transduction of cultured mouse
cell lines. Because efficient expression of transduced genes
TABLE II
Transduction efficiency of H2AX null cells and null cells
complemented with H2AX genes carrying mutation of the C-terminal
phosphorylation site of this histone
Cells were infected with an amphotropic ASV vector carrying an
EGFP reporter (23). Virus titer 1.4  105 infectious particles/ml. wt,
wild type.
Virus
dilution
EGFP-positive cells
H2AX/ H2AX/ H2AX/ wt H2AX
H2AX/ 
S136A/S139A
H2AX/ 
S136E/S139E
% % % % %
103 66.3 62.0 59.1 74.1 64.1
104 14.1 12.1 11.6 15.2 16.0
105 1.8 1.2 1.1 1.7 1.6
FIG. 4. Broken chromosomal ends may be held together by
several mechanisms to facilitate NHEJ. Proximity of ends pro-
duced by ionizing radiation (IR) or treatment with genotoxic agents
would be enhanced by H2AX-mediated anchoring via specific protein-
protein interactions. Ends produced during V(D)J recombination would
also be held together by the RAG1/2 protein complex (dashed oval).
Ends produced during retroviral integration are linked by single stand
covalent bonds to viral DNA and, perhaps, by the viral IN complex as
well.
FIG. 3. Association of viral DNA with H2AX. HeLa cells were infected and chromatin immunoprecipitation (IP) was performed as described
under “Experimental Procedures.” A, results are shown with nuclear lysates from cells at 6 h after infection with the ASV vector at m.o.i. 0.001,
0.01, or 0.1. PI-3K, phosphatidylinositol 3-kinase. Sup., supernatant. B, results are shown of H2AX ChIP assays with cells infected with the IN
and IN ASV vectors at m.o.i. 0.1. C, time course of association of H2AX with integrated viral DNA after infection at m.o.i. 0.1 is shown.
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requires stable retroviral vector integration, we conclude that
H2AX phosphorylation is largely dispensable for postintegra-
tion repair of chromatin damage.
Although H2AX is required for the accumulation of a subset
of repair and signaling proteins into irradiation-induced foci (7,
8, 24, 26, 27), the exact role of H2AX phosphorylation is not
well understood. Some DNA damage-sensing and repair pro-
teins have been shown to interact physically with H2AX (27–
29). A functional role for H2AX has been indicated because
H2AX-deficient cells are hypersensitive to ionizing radiation,
exhibit genomic instability, and also show an aberrant check-
point response under certain conditions (7, 8, 30). On the other
hand, although H2AX foci form at sites of V(D)J recombina-
tion, H2AX appears to be dispensable for this reaction when
tested with extrachromosomal substrates in cultured cells (7,
8, 30).
The study of H2AX-deficient mice has provided further in-
sight into H2AX function. H2AX mice are viable, but DNA
repair seems to proceed less efficiently in such animals, which
show modest sensitivity to ionizing radiation and impairment
in immunoglobulin class-switch recombination (31). In keeping
with results from the cell-based assays cited above, these mice
show no detectable abnormalities in V(D)J recombination (7,
8). However, the genomic caretaker function of H2AX is more
fully exposed when cell cycle checkpoints are compromised
because of the absence of p53 (25, 32). In a p53/ background,
even H2AX/ heterozygotes show increased misrepair of
DNA damage, leading to the development of immature T- and
B-cell lymphomas and solid tumors. Some of the B-cell lympho-
mas harbor oncogenic translocations with hallmarks of aber-
rant V(D)J recombination. It appears therefore that, although
H2AX is not required for V(D)J recombination, it can suppress
misrepair of RAG-dependent DSBs. Based on these and other
observations, two general, non-exclusive models have been pro-
posed for H2AX function. 1) The high concentration of repair
proteins recruited to the vicinity of DSBs by or through some
action of H2AXmay facilitate repair, especially at low (thresh-
old) levels of damage (30); or 2) H2AX interaction with such
proteins might help to hold broken ends together, thereby
minimizing the risk of misrepair (25, 32–34). According to
these models, differential dependency on H2AX is expected,
with more dependence on H2AX for the repair of free DSBs
formed by ionizing radiation than for programmed recombina-
tion reactions (e.g. V(D)J), in which ends are held in proximity
by recombination proteins (35). H2AX/ spermatocytes show
severe defects in meiotic X-Y chromosome pairing (12), and as
such, it is tempting to speculate that H2AX plays a bridging
function during meiotic recombination.
In summary, our studies have produced two important find-
ings. First, they provide direct confirmation that cultured cells
respond to retroviral DNA integration in the same way that they
respond to DSBs produced by a variety of genotoxic agents or
normal programmed events, namely, by massive phosphoryla-
tion of histone H2AX in the vicinity of the damage site. The
second finding is that H2AX appears to be dispensable for
postintegration repair. These observations lend independent sup-
port to a model in which the anchoring of broken DNA ends to
facilitate their repair is a critical function of H2AX. Because
chromosome breaks are likely to be held together by the RAG1/2
complex during V(D)J recombination and are held covalently by
viral DNA in retroviral integration (Fig. 4), such an anchoring
function should not be essential in either reaction.
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